Drugs like Ozempic and Wegovy with their promise to fight obesity effectively with around 15 to 20 per cent weight loss in its users, have been the talk of town ever since their launch in 2017 and 2021 respectively.
Generically known as semaglutide, this revolutionary drug has been found to be effective in controlling obesity, diabetes and a range of chronic diseases, which proves its effectiveness in tackling many health challenges beyond diabetes and obesity. According to studies, such GLP-1 medications reduce risk of heart attack, stroke, substance use, colorectal cancer, and Alzheimer's disease among others.
